Search results
FDA grants Shattuck Labs orphan drug status for AML treatment By Investing.com
Investing.com· 3 hours ago(NASDAQ:STTK), a biotechnology firm engaged in the development of fusion proteins for cancer and...
Shattuck Labs Gets FDA's Orphan Drug Status for Leukemia Treatment
Morningstar· 9 hours agoBy Dean Seal Shattuck Labs said federal regulators have granted orphan drug designation to its lead clinical candidate, a treatment for acute myeloid leukemia< ...
At 17, She Fell in Love With a 47-Year-Old. Now She Questions the Story.
New York Times· 12 hours agoJill Ciment’s 1996 memoir “Half a Life” described her teenage affair with the man she eventually...
Iomab-B shows promise in high-risk leukemia treatment By Investing.com
Investing.com· 9 hours agoThe Phase 3 SIERRA trial data indicated that Iomab-B, a targeted radiotherapy, met its primary...
Dr. Jeff Hersh addresses cause, effects and complications of Graft vs Host Disease
Gannett via AOL· 2 days agoGraft vs Host Disease occurs when white blood cells produced by donated stem cells identify the...
Celularity Inc. (NASDAQ:CELU) Sees Large Growth in Short Interest
ETF DAILY NEWS· 7 days agoCelularity Inc. (NASDAQ:CELU – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 627,100 shares, a growth of ...
Valrubicin-loaded immunoliposomes: A new technology to fight hematological cancer
Medical Xpress· 4 days agoValrubicin, a lipophilic chemical molecule similar to daunorubicin, has primarily been used in the treatment of bladder cancer. An article recently published in Cell Death & Disease ...
New cancer treatment increases efficacy by injecting chemo directly into tumor cells
BGR· 1 day agoChemotherapy has proven to be a fairly successful treatment for cancer. The Food and Drug...
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological...
Benzinga· 4 days agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin
ABC7's Eileen Whelan Shares Her Visionaries of the Year Fundraiser | 97.1 WASH-FM
iHeartRadio· 5 days agoABC7's Eileen Whelan shares her visionaries of the year fundraiser and could use your last minute...